These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 532690)

  • 1. A double blind comparison of viloxazine and amitryptyline in involutional and endogenous depression.
    Botter PA
    Acta Psychiatr Belg; 1979; 79(2):198-209. PubMed ID: 532690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile and serum concentration of viloxazine as compared to amitriptyline.
    Müller-Oerlinghausen B; Rüther E
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):321-37. PubMed ID: 386390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viloxazine in the treatment of depressive states.
    Rydzyński Z; Gruszczyński W
    Act Nerv Super (Praha); 1979 Oct; 21(3):146-7. PubMed ID: 556241
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double-blind trial of 2 antidepressive drugs].
    De León O; Kravcio JT; Sánchez C
    Acta Psiquiatr Psicol Am Lat; 1977 Sep; 23(3):215-20. PubMed ID: 341650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viloxazine and amitriptyline in depressive illness. A double blind controlled trial in general practice.
    Lennox IG; Asbury JF; Couldrick WG; Beswick KB
    Practitioner; 1978 Jan; 220(1315):153-6. PubMed ID: 343090
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nonpsychotic involutional inhibited depressions and psycho-organic deteriorations: treatment with Viloxazine and piracetam].
    Borromei A; Caramelli R; Conti M; Giancola LC; Guerra L
    Minerva Med; 1989 May; 80(5):475-82. PubMed ID: 2747975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synopsis of psychopathological, electroencephalographical, and pharmacokinetic variables during antidepressive treatment with viloxazine (author's transl)].
    Busch H; Bente D; Müller-Oerlinghausen B; Renfordt E
    Arzneimittelforschung; 1978; 28(8):1288-90. PubMed ID: 380579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double blind comparative trial of viloxazine and amitriptyline in patients suffering from endogenous depression.
    Kiloh LG; Bartrop RW; Franklin JA; Neilson MD
    Aust N Z J Psychiatry; 1979 Dec; 13(4):357-60. PubMed ID: 395939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of viloxazine (author's transl)].
    Brunner H; Huck F
    Encephale; 1980; 6(3):247-57. PubMed ID: 7449724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of maprotiline (Ludiomil) and viloxazine in the management of depressed patients in general practice.
    Lomas DM
    J Int Med Res; 1977; 5 Suppl 4():39-50. PubMed ID: 338401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
    Petrie WM; Ban TA; Wilson WH; Jamieson RC; Guy W
    Int Pharmacopsychiatry; 1982; 17(4):280-6. PubMed ID: 7185772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)].
    Pöldinger W
    Dtsch Med Wochenschr; 1982 Apr; 107(17):661-5. PubMed ID: 7075479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viloxazine in the treatment of depression: psychophysical measures and clinical response.
    Amin MM; Ban TA; Lehmann HE; Khan P
    Psychopharmacol Bull; 1978 Jan; 14(1):33-5. PubMed ID: 625536
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy profile of viloxazine. Open clinical trial with 34 patients].
    Pérez de Francisco C
    Neurol Neurocir Psiquiatr; 1976; 17(2):115-21. PubMed ID: 1052716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind study of the therapeutic efficacy and tolerability of amitriptylinoxide in comparison with amitriptyline.
    Tegeler J; Klieser E; Lehmann E; Heinrich K
    Pharmacopsychiatry; 1990 Jan; 23(1):45-9. PubMed ID: 2179974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.